Jeff E. Knight - Chief Dev. & Operating Officer at Crinetics Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Dev. & Operating Officer
Issuer Symbol
CRNX on Nasdaq
All Insider Reports
All Insider Reports

Jeff E. Knight - trading volume in the past year for Crinetics Pharmaceuticals, Inc.

Holdings reported by Jeff E. Knight for Crinetics Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 105,289 $4,222,088 $40.10 08 Apr 2026 Direct
Stock Option (Right to Buy) 65,977 08 Apr 2026 Direct Common Stock

Transactions reported by Jeff E. Knight for Crinetics Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.